Raymond James Financial
CLB icon

Raymond James Financial’s Core Laboratories CLB Stock Holding History

Raymond James Financial’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$545K Buy
+46,776
New +$668K ﹤0.01% 4444
2025
Q4 		– Sell
-208,114
Closed -$2.57M – 5191
2025
Q3 		$2.57M Sell
208,114
-13,351
-6% -$157K ﹤0.01% 2971
2025
Q2 		$2.55M Buy
221,465
+27,563
+14% +$327K ﹤0.01% 2877
2025
Q1 		$2.91M Sell
193,902
-196,652
-50% -$3.29M ﹤0.01% 2714
2024
Q4 		$6.76M Buy
+390,554
New +$7.54M ﹤0.01% 2126

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Raymond James Financial's CLB Position: Q2 2026 in Review

Raymond James Financial opened a new position in Core Laboratories (CLB) in Q2 2026: 46,776 shares worth $545K. The stake represents ﹤0.01% of the portfolio and ranks #4444 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in CLB as recently as Q3 2025.

Raymond James Financial first reported a position in CLB in Q4 2024 and has held it in 5 quarters since. The position peaked at $6.76M in Q4 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Raymond James Financial held 46,776 shares of Core Laboratories worth $545K as of Q2 2026.
  • Core Laboratories was a new Raymond James Financial position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4444 holding.
  • Raymond James Financial first reported a position in Core Laboratories in Q4 2024 and has held it in 5 quarters since.
  • Raymond James Financial's Core Laboratories position peaked at $6.76M in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.